首页> 外国专利> PHARMACEUTICAL PREPARATION CONTAINING CRYSTALLINE FORM I OR II OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT

PHARMACEUTICAL PREPARATION CONTAINING CRYSTALLINE FORM I OR II OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT

机译:包含5-氨基-2,3-二邻苯二甲酸酞嗪-1,4-二酮钠盐的结晶形式I或II的药物制剂

摘要

PROBLEM TO BE SOLVED: To provide a novel crystal of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt that is a pharmaceutical preparation for treating an inflammatory disease in which a symptom caused by an excessive immune response.SOLUTION: A pharmaceutical preparation contains the crystalline forms I and II of 5-amino-2,3-dihydrophthalazine-1,4-dione alkali salt, and has the crystallography values determined by means of x-ray powder diagrams, form I: d values: 13.5; 6.9; 5.2; 4.6; 3.9; 3.5; 3.4; 3.3; 3.1; 3.0 and 2-θ values: 6.5; 12.7; 16.9; 19.3; 22.8; 25.8; 26.6; 27.2; 28.7; 30.3, and form II: d values: 12.9; 7.9; 7.1; 6.5; 5.3; 4.0; 3.7; 3.6; 3.3; 3.2 and 2-θ values: 6.8; 11.2; 12.5; 13.7; 16.7; 22.4; 24.3; 24.9; 27.2; 27.8.SELECTED DRAWING: None
机译:解决的问题:提供一种新型的5-氨基-2,3-二氢邻苯二甲酸1,4-二酮钠盐晶体,这是一种用于治疗由过度免疫反应引起的症状的炎症性疾病的药物制剂。 :药物制剂包含5-氨基-2,3-二氢邻苯二甲酸1,4-二酮碱金属盐的晶型I和II,并具有通过X射线粉末图确定的晶体学值,形式I:d值:13.5; 6.9; 5.2; 4.6; 3.9; 3.5; 3.4; 3.3; 3.1; 3.0和2-θ值:6.5; 12.7; 16.9; 19.3; 22.8; 25.8; 26.6; 27.2; 28.7; 30.3,形式II:d值:12.9; 7.9; 7.1; 6.5; 5.3; 4.0; 3.7; 3.6; 3.3; 3.2和2-θ值:6.8; 11.2; 12.5; 13.7; 16.7; 22.4; 24.3; 24.9; 27.2; 27.8。选择的图纸:无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号